IntelliPharmaCeutics International Inc (IPCIF)
0.06
0.00 (0.00%)
USD |
OTCM |
May 21, 16:00
IntelliPharmaCeutics International Total Liabilities (Quarterly): 14.44M for Aug. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2023 | 14.44M |
| May 31, 2023 | 12.72M |
| February 28, 2023 | 12.53M |
| November 30, 2022 | 12.01M |
| August 31, 2022 | 11.59M |
| May 31, 2022 | 11.74M |
| February 28, 2022 | 10.90M |
| November 30, 2021 | 10.25M |
| August 31, 2021 | 9.625M |
| May 31, 2021 | 10.01M |
| February 28, 2021 | 9.869M |
| November 30, 2020 | 9.701M |
| August 31, 2020 | 8.902M |
| May 31, 2020 | 9.371M |
| February 29, 2020 | 8.437M |
| November 30, 2019 | 7.489M |
| August 31, 2019 | 6.570M |
| May 31, 2019 | 6.572M |
| February 28, 2019 | 6.646M |
| November 30, 2018 | 7.372M |
| August 31, 2018 | 10.59M |
| May 31, 2018 | 7.699M |
| February 28, 2018 | 8.116M |
| November 30, 2017 | 7.010M |
| August 31, 2017 | 7.451M |
| Date | Value |
|---|---|
| May 31, 2017 | 6.974M |
| February 28, 2017 | 7.088M |
| November 30, 2016 | 6.858M |
| August 31, 2016 | 3.614M |
| May 31, 2016 | 5.788M |
| February 29, 2016 | 4.868M |
| November 30, 2015 | 5.362M |
| August 31, 2015 | 3.878M |
| May 31, 2015 | 3.697M |
| February 28, 2015 | 3.132M |
| November 30, 2014 | 2.966M |
| August 31, 2014 | 3.430M |
| May 31, 2014 | 3.825M |
| February 28, 2014 | 3.559M |
| November 30, 2013 | 10.33M |
| August 31, 2013 | 5.492M |
| May 31, 2013 | 5.384M |
| February 28, 2013 | 5.204M |
| November 30, 2012 | 4.243M |
| August 31, 2012 | 6.526M |
| May 31, 2012 | 7.259M |
| February 29, 2012 | 7.936M |
| November 30, 2011 | 9.340M |
| August 31, 2011 | 11.44M |
| May 31, 2011 | 14.49M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.570M
Minimum
Aug 2019
14.44M
Maximum
Aug 2023
10.15M
Average
9.938M
Median
Total Liabilities (Quarterly) Benchmarks
| Acasti Pharma Inc | 11.50M |
| Aurinia Pharmaceuticals Inc | 170.11M |
| Edesa Biotech Inc | 2.151M |
| Lexaria Bioscience Corp | 0.2042M |
| Xenon Pharmaceuticals Inc | 31.32M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.566M |
| Shareholders Equity (Quarterly) | -12.88M |
| Debt to Equity Ratio | -0.1689 |
| Current Ratio | 0.0597 |
| Net Debt Paydown Yield | -1.59% |